Clinical trial of Psilocybin in the Treatment of Traumatic Brain Injury and stroke
Latest Information Update: 15 Aug 2021
At a glance
- Drugs Psilocybin (Primary)
- Indications Stroke; Traumatic brain injuries
- Focus Adverse reactions
- Sponsors Revive Therapeutics
- 15 Aug 2021 New trial record
- 10 Aug 2021 According to a Revive Therapeutics media release, the Company is proceeding to an FDA clinical study to be conducted at the University of Wisconsin-Madison, School of Medicine and Public Health and School of Pharmacy.
- 10 Aug 2021 According to a Revive Therapeutics media release, the company plans to start patient enrollment in this study in the Q4 of 2021